FILIERI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 1.088
EU - Europa 297
AS - Asia 267
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.654
Nazione #
US - Stati Uniti d'America 1.085
CN - Cina 136
SG - Singapore 82
UA - Ucraina 79
DE - Germania 74
TR - Turchia 49
IT - Italia 43
FI - Finlandia 37
GB - Regno Unito 27
SE - Svezia 20
RU - Federazione Russa 5
BE - Belgio 4
CA - Canada 3
NL - Olanda 3
FR - Francia 2
LT - Lituania 2
AT - Austria 1
BR - Brasile 1
EU - Europa 1
Totale 1.654
Città #
Woodbridge 158
Chandler 116
Jacksonville 90
Fairfield 87
Ashburn 85
Santa Clara 80
Singapore 71
Houston 60
Ann Arbor 48
Wilmington 43
Seattle 42
Nanjing 34
Cambridge 33
Izmir 26
Shanghai 22
Ferrara 21
Helsinki 19
Addison 18
Princeton 18
Dearborn 16
Boardman 14
Milan 10
Bremen 9
New York 9
Hebei 8
Shenyang 8
Beijing 7
Changsha 7
Jinan 6
San Diego 5
Brussels 4
Mountain View 4
Nanchang 4
Ningbo 4
Padova 4
Tappahannock 4
Tianjin 4
Auburn Hills 3
Falls Church 3
Frankfurt am Main 3
Hefei 3
Indiana 3
Jiaxing 3
Kunming 3
Toronto 3
Chengdu 2
Falkenstein 2
Guangzhou 2
Orange 2
Washington 2
Augusta 1
Baotou 1
Changchun 1
Haikou 1
Huzhou 1
Kilburn 1
Lanzhou 1
Los Angeles 1
Navegantes 1
Peschiera del Garda 1
Redwood City 1
Rome 1
San Francisco 1
San Mateo 1
Shaoxing 1
Shenzhen 1
Taizhou 1
Tomsk 1
Yellow Springs 1
Yinchuan 1
Totale 1.252
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 169
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 160
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 126
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 119
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 101
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 101
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 93
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 83
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 82
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 78
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 76
Real-time PCR is useful to detect menin gene deletions 76
A new VHL polymorphism in a big family from Ferrara 75
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 64
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 64
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 58
null 44
null 40
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  29
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 29
Totale 1.667
Categoria #
all - tutte 8.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 0 0 0 25 26 16 27 2 5
2020/2021206 16 26 27 37 2 19 9 21 4 19 22 4
2021/2022177 5 24 10 3 7 7 7 4 3 16 23 68
2022/2023222 22 27 12 29 38 29 10 16 25 1 6 7
2023/2024135 13 9 5 4 11 21 10 25 8 1 2 26
2024/2025207 10 2 39 9 57 87 3 0 0 0 0 0
Totale 1.667